T1	Chemical	89 98	BSC alone
T2	Chemical	101 111	anti- EGFR
T3	Gene_or_protein	99 115	, anti- EGFR mAb
T4	Chemical	99 136	, anti- EGFR mAb with chemotherapy or
T5	Chemical	139 148	C reduces
T6	Phenotype	161 176	progression and
T7	Phenotype	177 199	death of mCRC and that
T8	Disease	253 266	KRAS tumors .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	decreases	Arg1:T1	Arg2:T6
R4	decreases	Arg1:T1	Arg2:T7
R5	treats	Arg1:T1	Arg2:T8
R6	influences	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	decreases	Arg1:T2	Arg2:T5
R9	decreases	Arg1:T2	Arg2:T6
R10	decreases	Arg1:T2	Arg2:T7
R11	treats	Arg1:T2	Arg2:T8
R12	influences	Arg1:T3	Arg2:T2
R13	decreases	Arg1:T3	Arg2:T5
R14	decreases	Arg1:T3	Arg2:T6
R15	decreases	Arg1:T3	Arg2:T7
R16	treats	Arg1:T3	Arg2:T8
R17	influences	Arg1:T4	Arg2:T1
R18	influences	Arg1:T4	Arg2:T2
R19	influences	Arg1:T4	Arg2:T3
R20	decreases	Arg1:T4	Arg2:T5
R21	decreases	Arg1:T4	Arg2:T6
R22	decreases	Arg1:T4	Arg2:T7
R23	treats	Arg1:T4	Arg2:T8
R24	influences	Arg1:T5	Arg2:T1
R25	decreases	Arg1:T5	Arg2:T6
R26	decreases	Arg1:T5	Arg2:T7
R27	treats	Arg1:T5	Arg2:T8
R28	isAssociatedWith	Arg1:T6	Arg2:T1
R29	isAssociatedWith	Arg1:T6	Arg2:T4
R30	isAssociatedWith	Arg1:T6	Arg2:T5
R31	decreases	Arg1:T6	Arg2:T7
R32	isAssociatedWith	Arg1:T6	Arg2:T8
R33	isAssociatedWith	Arg1:T7	Arg2:T1
R34	isAssociatedWith	Arg1:T7	Arg2:T2
R35	isAssociatedWith	Arg1:T7	Arg2:T4
R36	isAssociatedWith	Arg1:T7	Arg2:T5
R37	isAssociatedWith	Arg1:T7	Arg2:T6
R38	isAssociatedWith	Arg1:T7	Arg2:T8
R39	influences	Arg1:T8	Arg2:T1
R40	influences	Arg1:T8	Arg2:T2
R41	influences	Arg1:T8	Arg2:T3
R42	influences	Arg1:T8	Arg2:T4
R43	influences	Arg1:T8	Arg2:T5
R44	influences	Arg1:T8	Arg2:T6
R45	influences	Arg1:T8	Arg2:T7
